#Veterinary Pain Management Market Analysis

[mitalipingale]

https://rollbol.com/blogs/1811907/Veterinary-Pain-Management-Market-Analysis-Size-Share-and-Forecast-2031

The Veterinary Pain Management Market in 2023 is US$ 1.92 billion, and is expected to reach US$ 3.29 billion by 2031 at a CAGR of 6.9%.

[credenceresearchdotblog]

The worldwide methylsulfonylmethane (MSM) market is anticipated to witness a compound annual growth rate (CAGR) of 3.68% between 2023 and 2030. Valued at USD 1,659.0 million in 2022, forecasts predict the market will mature to an estimated USD 2,136.98 million by 2030.Methylsulfonylmethane (MSM) is an organosulfur compound known for its anti-inflammatory and antioxidant properties. It has gained significant attention in various industries, including pharmaceuticals, nutraceuticals, cosmetics, and agriculture, due to its diverse range of applications. The global MSM market has witnessed substantial growth over the past few years, driven by increasing consumer awareness about health and wellness, rising demand for natural and organic products, and the expanding application base of MSM across different industries.

Browse the full report at https://www.credenceresearch.com/report/methylsulfonylmethane-market

Market Overview

The global MSM market has shown steady growth, with an increasing number of consumers recognizing its benefits for joint health, skin care, and overall wellness. The market is primarily driven by the aging population, which is more susceptible to joint-related issues, and the growing interest in natural and alternative therapies. Moreover, the rise in demand for dietary supplements and functional foods has further fueled the market's expansion.

Key Drivers

1. Growing Health and Wellness Trends: With a rising focus on health and wellness, consumers are increasingly turning to natural supplements to maintain their health. MSM, known for its joint pain relief and anti-inflammatory properties, has become a popular choice among those seeking natural remedies for conditions such as osteoarthritis.

2. Increasing Aging Population: The global aging population is one of the significant factors driving the demand for MSM. Older adults are more prone to joint pain and inflammation, making MSM an attractive option for managing these conditions. The compound's ability to improve joint mobility and reduce pain has made it a preferred ingredient in joint health supplements.

3. Rise in Demand for Natural Ingredients in Cosmetics: The cosmetic industry has seen a shift towards natural and organic ingredients, with consumers becoming more conscious of the products they use on their skin. MSM's ability to improve skin elasticity, reduce wrinkles, and promote a healthy complexion has led to its increased use in skincare products.

4. Expanding Application in Animal Health: MSM is not only beneficial for human health but also for animals. It is widely used in veterinary medicine to treat conditions such as arthritis in pets and to enhance the overall well-being of animals. The growing pet care market is expected to contribute to the increasing demand for MSM in the coming years.

Market Challenges

Despite the positive growth trends, the MSM market faces certain challenges. One of the primary challenges is the availability of synthetic substitutes that offer similar benefits at a lower cost. These alternatives can potentially limit the growth of the MSM market, particularly in price-sensitive regions. Additionally, the lack of awareness about MSM in developing regions may hinder market expansion.

Another challenge is the stringent regulatory environment governing the production and sale of dietary supplements and nutraceuticals. Manufacturers need to comply with various regulations and quality standards, which can increase the production costs and impact market growth.

Regional Analysis

The MSM market is geographically segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America currently dominates the market, driven by the high demand for dietary supplements and the presence of a large aging population. The region's well-established healthcare infrastructure and high consumer awareness further support market growth.

Europe is another significant market for MSM, with the increasing trend of using natural and organic products in cosmetics and personal care. The Asia-Pacific region is expected to witness the fastest growth during the forecast period, attributed to the rising health consciousness, increasing disposable income, and growing awareness about the benefits of MSM.

Competitive Landscape

The MSM market is highly competitive, with several key players actively involved in product innovation, research, and development. Major companies operating in the market include Bergstrom Nutrition, Inc., Hubei Xingfa Chemicals Group Co., Ltd., and Panvo Organics Pvt. Ltd. These companies are focusing on expanding their product portfolios and enhancing their production capabilities to meet the growing demand.

Future Outlook

The future of the MSM market looks promising, with increasing consumer inclination towards natural and organic products, coupled with the rising demand for dietary supplements and functional foods. Innovations in product formulations and the expanding application base of MSM across various industries are expected to create new growth opportunities for market players. However, companies need to address the challenges related to synthetic substitutes and regulatory compliance to fully capitalize on the market's potential.

Key Players:

OptiMSM

KALA Health

Bergstrom Nutrition

VitaFlex

Makana Produktion und Vertrieb GmbH

Segmentation Analysis

Food and Beverage

Pharmaceutical and dietary supplements

Cosmetics and Personal Care

Animal Feed

Other Industries (Agriculture, Urban Waste Handling, etc.)

Based on geographical distribution, the global methylsulfonylmethane market is segmented into the following categories:

North America

The U.S.

Canada

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/methylsulfonylmethane-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[industryforecastnews]

U.S. Veterinary Orthopedic Medicine Market Size, Share & Growth Analysis Report, 2030

U.S. Veterinary Orthopedic Medicine Market Growth & Trends

The U.S. veterinary orthopedic medicine market size is expected to reach USD 814.51 million by 2030, registering a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the increasing pet population, adoption of pet insurance, rising prevalence of diseases among animals, and advancements in veterinary medicine.

For instance, in October 2023, the FDA approved Librela (bedinvetmab injection), making it the first monoclonal antibody for treating osteoarthritis-related pain in dogs. In addition, in April 2022, American Regent Animal Health, a division of American Regent, Inc., received FDA approval to extend the shelf life of Adequan Canine and Adequan i.m. The expiration date for both products was increased from 24 months to 36 months from the date of manufacture.

Key players in the veterinary orthopedic medicine market are engaging in strategic initiatives like product launches, collaborations, and acquisitions to make their market presence more prominent, impelling market growth. In September 2022, Zoetis acquired Jurox, a private animal health company specializing in veterinary medicines for livestock and companion animals. The deal, finalized in August 2021, included Jurox's operations in Australia and regional offices in the U.S., Canada, and the UK. Such initiatives are anticipated to drive market growth.

For instance, in October 2023, Athersys, Inc. (ATHX), a cell therapy and regenerative medicine company, entered into a licensing agreement with Ardent Animal Health. With this move, Athersys, known for its work with MultiStem (invimestrocel) in critical care, entered the field of animal health. This collaboration with Ardent, a veterinary biotech firm specializing in regenerative medicine and cancer therapies for animals, highlights Athersys’ commitment to advancing veterinary care.    

Some key impacts of the pandemic and respective lockdowns on the market include dampened growth, decreased sales, supply chain disruptions, and operational challenges. However, the pandemic also propelled concerns over animal health and welfare, strengthened the pet parent and animal bond, and increased pet adoption. Moreover, the market witnessed an improved medicalization rate, pet expenditure, and adoption of pet insurance.

Increasing pet humanization and improved diagnostic rates were other positive impacts of the COVID-19 pandemic on the veterinary sector. In 2021, the market recorded increased demand and sale of veterinary medicines, including orthopedic medicines. In 2022, other macroeconomic uncertainties, such as global recession and cost inflation, adversely impacted the business. However, as the underlying market drivers remain unchanged owing to an increasing prevalence of orthopedic disorders in dogs and horses, the market is estimated to grow notably over the forecast period.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

U.S. Veterinary Orthopedic Medicine Market Report Highlights

Based on product, pharmaceuticals segment dominated the market, accounting for a share of 46.72% in 2023. Pharmaceutical treatments for orthopedic diseases in pets, such as Non-steroidal Anti-inflammatory Drugs (NSAIDs) and pain relievers, have been widely used and established as effective treatments for managing pain and inflammation. On the other hand, the viscosupplements segment is anticipated to grow at the fastest CAGR of 8.23% during the forecast period

Based on animal type, the market is segmented into dogs and horses. The dogs segment dominated the market, accounting for a share of 51.98% in 2023. It is also anticipated to grow at the fastest CAGR of 7.80% in the coming decade

Based on application, the osteoarthritis segment accounted for the largest share of 60.65% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 9.39% over the forecast period

Based on route of administration, the market is segmented into injectable, oral, and others (e.g., topical). The injectable segment dominated the market, accounting for a share of 60.40% in 2023. The others (e.g., topical) segment is anticipated to grow at the fastest CAGR of 8.22% in the coming decade

On the basis of end-use, veterinary clinics & hospitals segment accounted for the largest share of 53.59% of the market in 2023. The other segment is expected to grow at the fastest CAGR of 8.68% over the forecast period

U.S. Veterinary Orthopedic Medicine Market Segmentation

Grand View Research has segmented the U.S. veterinary orthopedic medicine market based on product, animal type, application, route of administration, and end-use:

U.S. Veterinary Orthopedic Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

Biologics

Stem Cells

Platelet-Rich Plasma (PRP)

Other Biologics

Viscosupplements

Pharmaceuticals

Steroids

NSAIDS

Others

U.S. Veterinary Orthopedic Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

Dogs

Small Breeds

Medium Breeds

Large Breeds

Horses

U.S. Veterinary Orthopedic Medicine Application Outlook (Revenue, USD Million; 2018 - 2030)

Osteoarthritis

Degenerative Joint Disease

Others

U.S. Veterinary Orthopedic Medicine Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

Injectable

Intra-Muscular

Intra-Articular

Others

Oral

Others

U.S. Veterinary Orthopedic Medicine End-use Outlook (Revenue, USD Million, 2018 - 2030)

Veterinary Hospitals & Clinics

At-home

Others

List of Key Players in the U.S. Veterinary Orthopedic Medicine Market

Zoetis Services LLC

Ardent Animal Health, LLC

Enso Discoveries

VetStem, Inc.

Contura Vet

PetVivo Holdings, Inc.

T-Cyte Therepeutics

Boehringer Ingelheim International GmbH

Arthrex, Inc.

MEDREGO LLC

Nucleus ProVets

Daiichi Sankyo Company, Limited 

Bimeda U.S.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/us-veterinary-orthopedic-medicine-market-report

[blog-site-for-market-research]

Understanding Market Share Dynamics: Veterinary CBD Market Sector Analysis

Market Overview –

The veterinary CBD market focuses on providing cannabidiol (CBD) products for pets, primarily dogs and cats, to address various health conditions and improve overall well-being. CBD is a non-psychoactive compound derived from the cannabis plant, known for its potential therapeutic effects on pain, inflammation, anxiety, seizures, and other health issues in animals.

Market growth is driven by increasing awareness among pet owners about the potential benefits of CBD for their pets and the growing acceptance of alternative and complementary therapies in veterinary care. As more pet owners seek natural and holistic approaches to pet health, there is a growing demand for CBD products as part of their pets' wellness routine.

Technological advancements and innovations in CBD extraction, formulation, and product development are shaping the market, offering a wide range of CBD-infused products such as oils, treats, capsules, and topical solutions for pets. These products are formulated with precise dosages and quality standards to ensure safety and efficacy for animals.

Moreover, the expanding legalization of cannabis-derived products and the deregulation of hemp cultivation in many countries are driving market growth, creating opportunities for manufacturers to develop and market CBD products for pets legally. Additionally, the COVID-19 pandemic has accelerated the adoption of CBD products for pets, as pet owners seek natural remedies to manage stress, anxiety, and behavioral issues in their pets during lockdowns and social distancing measures.

However, challenges such as regulatory uncertainties, quality control issues, and limited scientific research on the efficacy and safety of CBD for pets pose obstacles to market growth. Addressing these challenges requires collaboration between industry stakeholders, regulatory agencies, and veterinary professionals to establish clear guidelines, standards, and evidence-based practices for the use of CBD in veterinary medicine.

The veterinary CBD market is burgeoning as pet owners seek alternative treatments for their furry companions. Veterinary CBD treatment offers potential benefits for various conditions like anxiety, pain, and inflammation in pets. With increasing awareness and acceptance, the demand for CBD products tailored for pets is on the rise, creating opportunities for growth in the market.

At a compound annual growth rate of 53.4%, the veterinary CBD market is projected to reach USD 0.96 billion by 2032.

Segmentation –

In the veterinary CBD market, products are segmented by their source, with marijuana-derived and hemp-derived offerings each carving their niche within evolving legal frameworks. While marijuana-derived CBD gains ground in regions embracing legalization, hemp-derived CBD dominates due to its global legality. Products further segment into food-grade, led by treats and chews, and therapeutic-grade, poised for rapid growth with easing regulations. Food-grade items capitalize on pet owners' increasing expenditure, with treats and chews catering to specific needs, alongside supplements and oils.

Therapeutic-grade products, including supplements and oils, address various pet afflictions with promising research backing. Distribution channels vary, with e-commerce leading amidst legal ambiguities, followed by retail pharmacies for household pets, and veterinary clinics for livestock, expected to see significant growth. Other channels encompass direct manufacturer distribution and large-scale livestock farm orders.

Regional Analysis –

The veterinary CBD market experiences regional variations influenced by factors such as regulatory frameworks, pet ownership trends, and cultural attitudes towards alternative therapies. In regions with liberal regulations and a high prevalence of pet ownership like North America and Europe, the veterinary CBD market is thriving, with a wide range of products available for various animal health conditions. Conversely, in regions with stricter regulations or limited awareness of CBD benefits for pets, such as Asia-Pacific and Latin America, the market is still emerging, albeit with growing interest from pet owners and veterinarians. Moreover, cultural attitudes towards holistic and natural remedies shape the acceptance and uptake of CBD products in veterinary care across different regions. As research on the therapeutic benefits of CBD for pets continues to grow, regulatory harmonization and educational efforts are essential for unlocking the full potential of the veterinary CBD market globally.

Key Players –

Veterinary CBD companies reveals key players such as Joy Organics (US), Fomo Bones (US), Honest Paws (US), Canna-Pet (US), HolistaPet (US), HempMy Pet (US), Pet Releaf (US), Wet Noses (US), and Green Roads of Florida (US).

Related Reports –

Urinalysis Test

Celiac Disease Treatment

Healthcare Enterprise Software

Amniotic Membrane

For more information visit at MarketResearchFuture

[infinitiresearch]

Compounding Pharmacy Market - Forecast and Analysis, 2023-2027

Originally published on Technavio: Compounding Pharmacy Market by Product, Therapeutic Area and Geography, Industry Forecast and Analysis 2023-2027

The Compounding Pharmacy Market is poised for detailed analysis in the forecast period of 2023 to 2027, focusing on various aspects such as product types, therapeutic areas, and geographical regions. Compounding pharmacies play a critical role in preparing customized medications tailored to meet the specific needs of patients, particularly those who require personalized dosages, unique formulations, or have allergies to certain ingredients commonly found in mass-produced medications. This market analysis aims to provide insights into the trends, drivers, and challenges influencing the compounding pharmacy sector across different regions and therapeutic categories.

In terms of product types, compounding pharmacies offer a wide range of compounded medications, including oral medications, topical preparations, injectables, and others. The increasing demand for customized dosage forms, such as flavored liquids for pediatric patients, transdermal gels, and modified-release capsules, contributes to the growth of the compounding pharmacy market. Moreover, advancements in compounding techniques and technologies enable pharmacies to expand their product offerings and cater to diverse patient needs.

Therapeutic areas served by compounding pharmacies encompass a broad spectrum of medical specialties, including dermatology, pain management, hormone replacement therapy, veterinary medicine, and more. Compounded medications play a crucial role in addressing specific medical conditions or patient populations that may not be adequately served by commercially available medications. For example, compounded topical creams are commonly used in dermatology for treating conditions such as psoriasis or eczema, while customized hormone therapies are prescribed for managing menopausal symptoms.

Geographically, the compounding pharmacy market spans across various regions, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America, particularly the United States, dominates the global compounding pharmacy market due to factors such as the presence of a well-established healthcare infrastructure, favorable reimbursement policies, and increasing demand for personalized medicine. Europe follows closely, with countries like Germany, the UK, and France witnessing steady growth in compounding pharmacy services driven by rising healthcare expenditures and growing patient awareness about personalized healthcare options.

In Asia-Pacific, countries such as China, India, and Japan are emerging as lucrative markets for compounding pharmacy services due to factors like increasing healthcare expenditure, expanding access to healthcare services, and growing adoption of personalized medicine approaches. Moreover, regulatory reforms aimed at standardizing compounding practices and ensuring patient safety contribute to market growth in the region.

To Learn deeper into this report , View Sample PDF

Overall, the forecast period from 2023 to 2027 presents opportunities for compounding pharmacies to capitalize on emerging trends such as precision medicine, telemedicine, and digital health solutions to enhance patient care and expand their market presence. By understanding the diverse needs of patients and healthcare providers, compounding pharmacies can develop innovative products and services to address unmet medical needs and improve patient outcomes in the global healthcare landscape.

For more information please contact.

Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: www.technavio.com/

[priyanshisingh]

Compounding Pharmacies Market - Future Growth Prospects for the Global Leaders

The latest market report published by Credence Research, Inc. “Global Compounding Pharmacies Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for Compounding Pharmacies was valued at USD 13154.8million in 2022 and is expected to reach USD 20188.4 Million in 2030, growing at a CAGR of 5.50% between 2023 and 2030.

Compounding Pharmacies market has gained prominence in the healthcare industry as a vital source of customized medications tailored to meet individual patient needs. Compounding pharmacies specialize in preparing medications that are not readily available in standard drug formulations or require specific dosages, flavors, or delivery forms, such as creams, gels, or lozenges. This market addresses the unique healthcare requirements of patients who may have allergies to certain ingredients, require pediatric or geriatric dosages, or need medications free from preservatives or dyes.

One key driver of growth in the compounding pharmacy market is the increasing demand for personalized medicine, where medications are customized to suit each patient's unique medical conditions and preferences. Additionally, compounding pharmacies play a crucial role in serving patients with rare diseases or those in need of specialized hormone therapy, pain management, dermatological, or ophthalmic preparations.

Compounding Pharmacies Market Top Trends refer to the prevailing patterns and developments within the compounding pharmacies industry. As demand for customized medications continues to rise, compounding pharmacies have emerged as crucial players in the healthcare sector. One notable trend is the growing popularity of personalized medicine, where compounded drugs are tailored to meet each patient's unique needs. This approach allows physicians to address specific health conditions more effectively while considering factors like allergies or dosage preferences. Another significant trend is the integration of technology into compounding processes, enabling increased precision and efficiency in drug preparation. Automation systems and robotic technologies have streamlined compounding procedures, minimizing errors and reducing turnaround time for patients.

Browse 245 pages report Compounding Pharmacies Market By Type of Compounding (Non-Sterile Compounding, Sterile Compounding) By End-User (Patients, Hospitals and Healthcare Facilities, Veterinary Compounding) -Growth, Future Prospects & Competitive Analysis, 2022 – 2030 https://www.credenceresearch.com/report/compounding-pharmacies-market

List of the prominent players in the Compounding Pharmacies Market:

Galderma S.A.

Allergan PLC

Merz Pharma

Laboratory ObvieLine

Bausch Health Companies Inc.

La Roche-Posay

IMAGE SKINCARE

Glytone

Here are some recommendations for stakeholders in the Compounding Pharmacies market:

Compliance with Regulations: Ensure strict compliance with regulatory guidelines and quality standards governing compounding pharmacies. This includes adhering to Good Manufacturing Practices (GMP) and regularly reviewing and updating procedures to meet evolving regulatory requirements.

Invest in Quality Assurance: Establish rigorous quality control processes and invest in quality assurance to maintain the safety, efficacy, and consistency of compounded medications. Regular testing and validation of compounded formulations are essential.

Continuous Training and Education: Provide ongoing training and education for compounding pharmacy staff, including pharmacists, technicians, and support personnel. Staying up-to-date with the latest compounding techniques, safety measures, and regulatory changes is critical.

Transparent Communication: Foster transparent communication with healthcare providers, patients, and regulatory authorities. Clear and accurate labeling, as well as detailed instructions for use, can enhance patient safety and satisfaction.

Patient-Centric Approach: Maintain a patient-centric focus by actively engaging with patients and their healthcare providers to understand their unique medication needs and preferences. Tailor compounded formulations accordingly.

Collaborate with Healthcare Providers: Build strong collaborative relationships with healthcare providers, including physicians, nurse practitioners, and veterinarians. Effective communication and collaboration are key to meeting patient needs.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Compounding Pharmacies Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Compounding Pharmacies Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major player analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/compounding-pharmacies-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/cocaine-rapid-test-kit-market

Related Report: https://www.credenceresearch.com/report/cryoablation-catheters-market

Browse Our Blog: https://www.linkedin.com/pulse/compounding-pharmacies-market-size-analyzing-lmkzf

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[severepeanutperfection]

Animal Wound Care Market Share and Growth Factors Impact Analysis 2032

The Animal Wound Care Market is a rapidly growing industry that focuses on providing effective and advanced solutions for treating wounds in animals. With a deep understanding of the importance of animal welfare, this market offers a wide range of products and services specifically designed to address various types of wounds in different animal species. From minor cuts and abrasions to complex surgical wounds, the Animal Wound Care Market plays a crucial role in promoting the well-being and recovery of animals.

One of the key drivers behind the growth of the Animal Wound Care Market is the increasing pet ownership and the growing concern for animal health and wellness. As more people embrace pets as integral members of their families, the demand for high-quality wound care products and treatments also rises. Furthermore, the rise in veterinary healthcare expenditure and the advancements in veterinary medicine contribute to the expansion of the market.

The Animal Wound Care Market offers a diverse range of products, including wound dressings, bandages, sutures, and wound healing ointments. These products are designed to provide effective wound management, promote healing, prevent infections, and reduce pain and discomfort in animals. Additionally, the market encompasses specialized wound care services provided by veterinary professionals, including wound assessment, debridement, and customized treatment plans.

For More Info@ https://www.persistencemarketresearch.com/market-research/animal-wound-care-market.asp

With ongoing research and development efforts, the Animal Wound Care Market continues to witness advancements in technologies and innovative products. These advancements aim to improve the efficiency of wound healing, minimize scarring, and enhance the overall outcomes of wound care in animals. As the market expands, it also fosters collaborations between veterinary professionals, pharmaceutical companies, and research institutions to further drive innovation and ensure the highest standards of care for animals in need of wound treatment.

[petnews2day]

Veterinary Pain Management Market is Projected to Cross USD 2.15 Billion by 2028 at a CAGR of 7% from 2022 to 2028; Growing Awareness about Pain Management in Animals and the Advent of Innovative Therapies to Boost Market Growth

New Post has been published on https://petn.ws/z8bH8

Veterinary Pain Management Market is Projected to Cross USD 2.15 Billion by 2028 at a CAGR of 7% from 2022 to 2028; Growing Awareness about Pain Management in Animals and the Advent of Innovative Therapies to Boost Market Growth

SkyQuest Technology Consulting Pvt. Ltd. The veterinary pain management market is experiencing significant growth in recent years, and industry experts predict continued expansion in the coming years. SkyQuest’s research report offers a comprehensive analysis of the market, providing valuable insights for stakeholders in the industry. Furthermore, the report offers expert insights and analysis supported by […]

See full article at https://petn.ws/z8bH8 #PetFinancialNews

[super-brandessence1]

Brandessence Market Research is working on a new report title “Veterinary Pain Management Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

[marketresearchshope-blog]

Veterinary Pain Management Drugs Market: Intelligence Study on Transformation 2025

Global Veterinary Pain Management Drugs Market to 2025 based on segments, growth rate, revenue, leading players, regions and forecast. The Veterinary Pain Management Drugs market is escalating at a rapid pace with the invention of the new dynamism that is progressing rapidly.

Objective:

The global Veterinary Pain Management Drugs market report is comprehensive research which delivers critical predictions. Our research analysts curated the Table of Contents as per the latest trends and requirements, and the report provides the precise calculation of the Veterinary Pain Management Drugs market regarding the advanced development which depends on the historical data and current condition of industry status. It renders the required secondary data that represents the Veterinary Pain Management Drugs tables, figures, pie charts, diagrams, etc.

Grab Free Sample Report at: http://www.marketresearchglobe.com/request-sample/941031

Global Veterinary Pain Management Drugs Market Segment by Manufacturers comprises:Boehringer Ingelheim, Merck & Co, Zoetis, Elanco, Bayer Pharma AG, Ceva Sante Animale, Norbrook Laboratories, Baxter, Halyard, Bostonscientific, Lilly, Endo International, Forest Laboratories, Medtronic

Veterinary Pain Management Drugs Market With Product Types:

Opioids

α2-Adrenergic Agonists

Local Anesthetics

Nonsteroidal Anti-Inflammatory Drugs (NSIDs)

Sedatives

Corticosteroids

Other

From Applications, the Veterinary Pain Management Drugs Market could be Put up:

Veterinary Hospitals

Veterinary Clinics

For Retail

Veterinary Pain Management Drugs Market Segment by Regions comprises:

North America, Europe, Asia-Pacific, South America and The Middle East and Africa.

Points Presented in the Veterinary Pain Management Drugs Report:

Veterinary Pain Management Drugs Research offers businesses a list that's currently choosing the most expansion.

Shows threatening contracts and Veterinary Pain Management Drugs impending relation between material providers and vendors and vendors.

Facets of Veterinary Pain Management Drugs industry and success are functioned in this study.

Skilled Veterinary Pain Management Drugs SWOT (Strengths, Weaknesses, Opportunities, and Risks) and also PESTEL (Political, Economic, Social, Technological, Environmental and Legal) research is supreme.

Import/send-out detail, Veterinary Pain Management Drugs type analysis, prediction planning and approaches profit, and also technological progress of manufacturers are mentioned in this research.

Get it in Discounted Price at: http://www.marketresearchglobe.com/check-discount/941031

Additionally, the Veterinary Pain Management Drugs factors highlighted in the report are revenue, sales, manufacturing cost and production, which states the competitive aspect in the lucrative idea of the market share. The Veterinary Pain Management Drugs economic background and financial troubles across the globe are discussed in the report along with the CAGR value during the forecast period up to 2025.

Precisely What Veterinary Pain Management Drugs Market Report Offers:

Veterinary Pain Management Drugs market offers evaluations for your county level evaluation together using manufacture, ingestion, earnings;

Industry supplies Veterinary Pain Management Drugs businesses with gross profit margin, merchandise classification, revenue earnings, cost, and advice;

Market predictions of five decades of the Veterinary Pain Management Drugs segments;

In the Veterinary Pain Management Drugs pipeline for the applicants;

Business series Veterinary Pain Management Drugs investigation, procedures, manufacture and cost inquiry, style of transportation and price evaluation;

Veterinary Pain Management Drugs supply chain series tendencies planning the brand new progressions;

International Veterinary Pain Management Drugs market stocks drivers, limitations, prospects, dangers, challenges and investment prospects;

Company summarizing with Veterinary Pain Management Drugs methodical plans, financials, and also current advancements;

Ask our Expert Enquire Here: http://www.marketresearchglobe.com/send-an-enquiry/941031

About Us: Market Research Globe is a competent consulting company in the field of Global Market Research. We provide our clients a wide range of customized Marketing and Business Research Solutions to choose from, with the help of our ingenious database developed by experts. We help our clients understand the strengths of diverse markets and how to exploit opportunities. Covering a diverse range of business scopes from Digital products to Food industry, we are your one- stop solution right from data collection to investment advices.

Contact Us: Market Research Globe Call:+1-888-376-9998 Email: sales@marketresearchglobe.com News: https://peopleheraldtoday.com Blog: https://eaglechronicle.com

[medicaldevicetech]

Veterinary Pain Management Market 2019 Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities by 2023

Market Highlights:

Veterinary Pain Management Market is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.

Get Sample PDF @https://www.marketresearchfuture.com/sample_request/5961

Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).

Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.

Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.

Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.

On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.

Veterinary Pain Management Market   - Segmentations MRFR has segmented the analysis into seven key dynamics for better understanding: -

By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.

By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.

By Route of Administration: Oral, Parenteral, and Topical among others. 

By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.

By Application: Joint Pain, Postoperative Pain, and Cancer among others.

By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Veterinary Pain Management Market   - Geographical Analysis The North American region accounts for the leading market for veterinary pain management majorly due to the availability of a range of animal care products, emphasis on animal health, and stringent government regulations.  Also, technological innovations in the field of veterinary surgical instruments are acting as a tailwind pushing up the market growth in the region. 

Additional factors such as growing insurance coverage schemes are expected to push the growth of the veterinary pain management market in the region. Moreover, the increasing number of pets and a large patients’ pool, contribute to the growth of the regional market, demanding various treatment procedures and surgeries.

Countries such as Canada and the US are focusing on exporting surgical equipment and surgical suturing material across the world, which, in turn, is increasing the size of the market in this region. Besides, the growing number of veterinary hospitals fuel market growth.

The Veterinary Pain Management Market in the European region stands the second position in terms of the market size, owing to the increasing pet ownership fuelled by the tax benefits granted by the government.  Increase in animal diseases has led to an increasing number of surgeries and veterinary healthcare organizations. European countries like Germany, France, and the U.K, backed by the significant expenditures in the field of manufacturing of veterinary medical and surgical devices, majorly contributes to the growth of the regional market.

The Asia Pacific region is emerging as a promising market for companion veterinary pain management. China among other APAC dominates the regional market whereas, India accounts for the fastest growing market, followed by Australia and Japan.  Factors such as the presence of a large patient’s pool, increasing awareness towards animal health, and the improving economy are few of the driving forces pushing up the market in the region.

Veterinary Pain Management Market   - Competitive Landscape The fiercely competitive veterinary pain management market appears to be fragmented due to many players forming a competitive landscape. Mergers & acquisitions, innovations, and Brand reinforcement remain the popular trends for the market players. Acquisitions of local manufactures by multinational companies are changing the market structure, increasing the profit of the company by reducing the competition significantly.

Key Players: Some of the players leading the market include Zoetis, Boehringer Ingelheim, Chanelle, Ceva Santé Animale, Dechra Pharmaceuticals, Norbrook Laboratories, Merck Animal Health, Elanco, Assisi Animal Health, Bayer, and Vetoquinol.

Industry/ Innovation/ Related News:

November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com